TQS sets a High Bar in Serialization and Aggregation Lines at Boehringer Ingelheim
Compliance by Precision
As one of the world’s 20 leading pharmaceutical companies, the Boehringer Ingelheim group operates globally with 175 affiliates and employs more than 51,000 professionals. Since it exports pharmaceuticals to different markets worldwide, implementing all necessary anti-counterfeiting measures and complying with serialization and anti-tampering requirements of different countries is an absolute prerequisite on the company’s agenda. As part of its large-scale compliance project, the pharmaceutical company equipped its production lines with state-of-the-art serialization and aggregation technology from WIPOTEC-OCS. Boehringer Ingelheim’s strategic investment has led to a successful implementation and assuring the reliable anti-counterfeit protection combined with serialization of pharmaceutical products and thereby meeting the ultimate goal of enhancing patient health and safety.